Frequently asked questions

Find answers to FAQs about Qelbree for ADHD in adults and children 6 years and older. 

Decorative
FAQ Sections

General FAQs on Qelbree

Find the answers to some common questions.

FAQ Section Items
What is Qelbree?

Qelbree is a non-stimulant treatment for ADHD in adults and kids ages 6 years and older. It’s a once-a-day capsule that has been proven to help significantly reduce symptoms of ADHD in medical studies when compared to placebo. It offers 24-hour full day coverage, and can be taken at any time of the day.

How is Qelbree taken?

There are 2 ways to take once-a-day Qelbree:

  • The capsule can be swallowed whole.
  • The capsule can be opened and the entire contents sprinkled on a spoonful of applesauce and must be all consumed, without chewing, within 2 hours. Contents can also be sprinkled on pudding and must be all consumed, without chewing, within 15 minutes. Do not store for future use.

Do not cut, crush, or chew the capsules.

Learn more about dosing for adults

Learn more about dosing for children ages 6 years and older

Do I need a new prescription every month to refill Qelbree?

Qelbree is not a controlled medication, and it can be conveniently refilled without the need for new prescriptions each month. Your healthcare provider may opt to prescribe a 90-day prescription.

Learn more about the benefits of non-stimulant Qelbree

Where can I learn about the experiences of others who take Qelbree?

Follow the link below to see real stories from adults taking Qelbree and parents with children taking Qelbree.

See real Qelbree Stories

What should I ask my healthcare provider if I think I have ADHD? About Qelbree?

If you or your child are experiencing symptoms of ADHD, it’s important to talk about them, as well as treatment options with your healthcare provider. You can download a free, customized discussion guide to help you get the most out of talking to your healthcare provider.

Create discussion guide for myself

Create discussion guide for my child

Does gender affect ADHD?

While gender can’t completely predict someone’s ADHD journey, there can be differences in how women and men—and boys and girls—present their ADHD symptoms. This commonly factors into diagnosis.

Read about ADHD in men and women

Read about ADHD in boys and girls

Do symptoms of ADHD change with age?

ADHD can look different based on age. Different symptoms may surface through phases of life. Knowing more about this can help you understand and monitor symptoms.

Learn how ADHD can be different in children and teens

Learn about ADHD in adulthood

Is ADHD genetic?

It can be. Nearly 80% of people with ADHD inherited the condition from a family member.

Pediatric FAQs

Answers to FAQs on Qelbree for children ages 6-17 years

FAQ Section Items
What are the possible side effects of Qelbree?

In medical studies, the most common side effects were sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability.

These are not all the possible side effects of Qelbree. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Learn more about potential side effects

How long does Qelbree take to work?

Your child's healthcare provider will determine the right dose for them based on their response to Qelbree. They may find the right dose in 1-3 weeks. Qelbree is a non-stimulant medication and has a “gradual onset.” It could take a few weeks for the medication to be fully effective.

Qelbree met the goal of 3 different medical studies—a significant reduction in ADHD symptom scores in 6 or 8 weeks. For some children, Qelbree reduced ADHD symptom scores as early as Week 1.

Learn more about results with Qelbree

Will Qelbree help improve my child’s ADHD symptoms?

In medical studies, Qelbree was proven to help reduce ADHD symptoms when compared to placebo. Reducing the impact of those symptoms may improve your child’s ADHD at home and at school.

Learn more about results with Qelbree

Adult FAQs

Find answers about Qelbree tailored to adults

FAQ Section Items
What are the possible side effects of Qelbree?

In a medical study in adults, the most common side effects were insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation.

These are not all the possible side effects of Qelbree. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Learn more about possible side effects

What if I take Qelbree and am considering breastfeeding?

Qelbree is the first and only ADHD treatment to meet the 2019 FDA guidance for clinical lactation studies. If you are taking Qelbree and plan on breastfeeding, talk to your doctor.

Learn about Qelbree and lactation evidence

Can Qelbree help with tasks impacted by ADHD?

In a medical study, Qelbree was proven to help reduce ADHD symptoms compared to placebo. By reducing the impact of ADHD symptoms, Qelbree may help with the everyday tasks that are complicated by your ADHD.

Learn more about results with Qelbree

When can I expect Qelbree to start working?

Your healthcare provider will determine the right dose for you based on your response to Qelbree. You may find the right dose in 1-2 weeks. Qelbree is a non-stimulant medication and has a “gradual onset.” It could take a few weeks for the medication to be fully effective.

In the 6-week medical study, adults taking Qelbree met the goal of a significant reduction in ADHD symptom scores at Week 6. For some adults, Qelbree reduced ADHD symptom scores as early as Week 2.

Learn more about results with Qelbree

Multiple Card Cards
Single Card Icon or Image

Talk to your healthcare provider

Get a free, personalized questionnaire to help inform your conversation.
Single Card CTA Button
Single Card Icon or Image

Cost and savings

Qualified patients may pay as little as $20 per prescription.*
Single Card CTA Button
Single Card Icon or Image

Stay informed

Get information about Qelbree and managing ADHD with the Qelbree Insider.
Single Card CTA Button

*Terms and Conditions

This offer is good for most commercially insured and cash-paying patients purchasing Qelbree® and may not be used for any other product. Maximum benefits and quantity of capsules may apply. This offer is not valid for prescriptions purchased under Medicaid, Medicare, or other federal or state programs (such as medical assistance programs). Offer not valid where prohibited by law, taxed, or restricted. It is not transferable and may not be combined with any other offer. The amount of the rebate cannot exceed the patient’s actual out-of-pocket expenses. Offer must be presented along with a valid prescription for Qelbree at the time of purchase. By enrolling into this program you are consenting to the collection and use of certain personal information, including your phone number and/or email address and elements of pharmacy claim information. This information will be collected and used by service providers of Supernus Pharmaceuticals, Inc. (“Supernus”), in order to administer this program. This information is not provided to Supernus directly. If you do not consent, please do not enroll into the program. If you require additional assistance, please call 1-866-398-0833. Supernus reserves the right to rescind, revoke, or amend this offer without notice at any time.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.